Immunome Inc

General ticker "IMNM" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $761.1M

Immunome Inc does not follow the US Stock Market performance with the rate: -7.3%.

Estimated limits based on current volatility of 2.8%: low 10.63$, high 11.25$

Factors to consider:

  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [6.21$, 14.92$]
  • 2024-12-30 to 2025-12-30 estimated range: [5.10$, 12.53$]

Financial Metrics affecting the IMNM estimates:

  • Negative: Non-GAAP EPS, $ of -1.71 <= 0.10
  • Negative: Operating profit margin, % of -88.65 <= 1.03
  • Negative: Operating cash flow per share per price, % of -4.59 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term IMNM quotes

Long-term IMNM plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $14.02MM
Operating Expenses $25.20MM $36.90MM $123.55MM
Operating Income $-25.20MM $-36.90MM $-109.53MM
Non-Operating Income $0.49MM $0.01MM $2.72MM
Interest Expense $0.01MM $0.00MM $0.00MM
R&D Expense $14.11MM $23.27MM $80.80MM
Income(Loss) $-24.71MM $-36.90MM $-106.81MM
Profit(Loss) $-24.71MM $-36.90MM $-106.81MM
Stockholders Equity $48.19MM $16.65MM $119.88MM
Inventory $4.31MM $0.85MM $0.00MM
Assets $57.92MM $24.05MM $148.54MM
Operating Cash Flow $-18.23MM $-28.69MM $-7.57MM
Capital expenditure $0.08MM $0.25MM $0.83MM
Investing Cash Flow $-0.08MM $-0.25MM $-30.48MM
Financing Cash Flow $27.77MM $0.03MM $116.41MM
Earnings Per Share* $-2.12 $-3.09 $-5.38

* EPS are Split Adjusted, recent splits may be reflected with a delay.